FIELD: pharmaceutical industry.
SUBSTANCE: group of inventions refers to a combination for preventing or treating tinnitus and a method for preventing or treating tinnitus in a subject. A combination for preventing or treating tinnitus containing plasma enriched with thrombocytes (PRP) and dexamethasone in effective amounts. A method for preventing or treating tinnitus in a subject, comprising administering the combination into a tympanic cavity of a subject.
EFFECT: composition described above enables effective treatment and prevention of tinnitus.
11 cl, 2 dwg, 3 tbl, 1 ex
Authors
Dates
2020-04-30—Published
2016-08-26—Filed